McKesson (NYSE: MCK)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
McKesson Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
McKesson Company Info
Providing supply, information and care management products and services designed to reduce costs and improve quality across the healthcare industry.
News & Analysis
The Oracle of Omaha has added a bunch of stocks that have lost value lately, but this one is standing out with its performance.
Are these high-flying Buffett stocks still smart picks to buy now?
Two of the three are new positions for Berkshire Hathaway.
They perhaps, not so coincidentally, are all in the pharmaceutical business.
The COVID-19 pandemic served as a tailwind for the big healthcare supply chain management company.
One medical distribution company has been through this before.
Producer Johnson & Johnson, and distributors McKesson, AmerisourceBergen, and Cardinal Health will all be expected to contribute to the settlement.
The big healthcare company faced COVID-19 headwinds. But its business improved more strongly than expected.
Valuation
Earnings Transcripts
MCK earnings call for the period ending June 30, 2022.
MCK earnings call for the period ending March 31, 2022.
MCK earnings call for the period ending December 31, 2021.
MCK earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.